| Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults D Hoelzer, E Thiel, H Loffler, T Büchner, A Ganser, G Heil, P Koch, ... | 775 | 1988 |
| Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German … P Koch, F del Valle, WE Berdel, NA Willich, B Reers, W Hiddemann, ... Journal of clinical oncology 19 (18), 3861-3873, 2001 | 652 | 2001 |
| Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study A Engert, V Diehl, J Franklin, A Lohri, B Dörken, WD Ludwig, P Koch, ... Journal of Clinical Oncology 27 (27), 4548-4554, 2009 | 635 | 2009 |
| Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage … A Engert, P Schiller, A Josting, R Herrmann, P Koch, M Sieber, ... Journal of Clinical Oncology 21 (19), 3601-3608, 2003 | 566 | 2003 |
| Improved outcome in adult B-cell acute lymphoblastic leukemia D Hoelzer, WD Ludwig, E Thiel, W Gaßmann, H Loffler, C Fonatsch, ... | 432 | 1996 |
| New prognostic score based on treatment outcome of patients with relapsed Hodgkin’s lymphoma registered in the database of the German Hodgkin’s lymphoma study group A Josting, J Franklin, M May, P Koch, MK Beykirch, J Heinz, C Rudolph, ... Journal of Clinical Oncology 20 (1), 221-230, 2002 | 406 | 2002 |
| Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma … A Engert, J Franklin, HT Eich, C Brillant, S Sehlen, C Cartoni, R Herrmann, ... Journal of Clinical Oncology 25 (23), 3495-3502, 2007 | 342 | 2007 |
| Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma—results of the … P Koch, F del Valle, WE Berdel, NA Willich, B Reers, W Hiddemann, ... Journal of clinical oncology 19 (18), 3874-3883, 2001 | 316 | 2001 |
| Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96) P Koch, A Probst, WE Berdel, NA Willich, G Reinartz, J Brockmann, ... Journal of clinical oncology 23 (28), 7050-7059, 2005 | 306 | 2005 |
| ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ... Annals of Oncology 24 (3), 561-576, 2013 | 255 | 2013 |
| Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment U Rueffer, K Breuer, A Josting, B Lathan, M Sieber, O Manzke, ... Annals of Oncology 12 (9), 1307-1311, 2001 | 245 | 2001 |
| Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non … K Behringer, H Goergen, F Hitz, JM Zijlstra, R Greil, J Markova, S Sasse, ... The Lancet 385 (9976), 1418-1427, 2015 | 222 | 2015 |
| BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease V Diehl, M Sieber, U Rüffer, B Lathan, D Hasenclever, M Pfreundschuh, ... Annals of oncology 8 (2), 143-148, 1997 | 190 | 1997 |
| Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin’s disease: long-term results of a randomized trial of … E Dühmke, J Franklin, M Pfreundschuh, S Sehlen, N Willich, U Rühl, ... Journal of clinical oncology 19 (11), 2905-2914, 2001 | 157 | 2001 |
| Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group. MG Pfreundschuh, U Rueffer, B Lathan, N Schmitz, O Brosteanu, ... Journal of Clinical Oncology 12 (3), 580-586, 1994 | 143 | 1994 |
| 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin’s lymphoma: results of a … M Sieber, H Bredenfeld, A Josting, T Reineke, U Rueffer, T Koch, ... Journal of clinical oncology 21 (9), 1734-1739, 2003 | 119 | 2003 |
| Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease. M Loeffler, V Diehl, M Pfreundschuh, U Rühl, D Hasenclever, ... Journal of clinical oncology 15 (6), 2275-2287, 1997 | 110 | 1997 |
| Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study NA Willich, G Reinartz, EJ Horst, G Delker, B Reers, W Hiddemann, ... International Journal of Radiation Oncology* Biology* Physics 46 (4), 895-901, 2000 | 98 | 2000 |
| Primary lymphoma of the stomach: Three-year results of a prospective multicenter study P Koch, B Grothaus-Pinke, W Hiddemann, N Willich, B Reers, F Del Valle, ... Annals of oncology 8, S85-S88, 1997 | 91 | 1997 |
| Moderate dose escalation for advanced stage Hodgkin’s disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and … H Tesch, V Diehl, B Lathan, D Hasenclever, M Sieber, U Ruffer, A Engert, ... Blood, The Journal of the American Society of Hematology 92 (12), 4560-4567, 1998 | 87 | 1998 |
